Table 2 Characteristics of the included preprints in total and according to prevention type.
Total n/N (%) | COVID-19 topic n/N (%) | External funding n/N (%) | |
---|---|---|---|
Total | 329 | 242/329 (73.6%) | 169/329 (51.4%) |
Prevention type | |||
Screening | 152/329 (46.2%) | 107/152 (70.4%) | 91/152 (59.9%) |
Immunization | 66/329 (20.1%) | 45/65 (69.2%) | 30/66 (45.4%) |
Chemoprevention | 16/329 (4.9%) | 8/16 (50.0%) | 10/16 (62.5%) |
Counseling | 2/329 (0.6%) | 0/2 (0%) | 2/2 (100%) |
Other primary prevention | 90/329 (27.4%) | 81/90 (90.0%) | 34/90 (37.8%) |
Other secondary prevention | 3/329 (0.9%) | 1/3 (33.3%) | 1/3 (33.3%) |